Literature DB >> 10612830

p53 website and analysis of p53 gene mutations in human cancer: forging a link between epidemiology and carcinogenesis.

T Soussi1, K Dehouche, C Béroud.   

Abstract

The p53 tumor suppressor gene has proven to be one of the genes most often mutated in human cancers. It involves mainly point mutations leading to amino acid substitutions in the central region of the protein which impairs normal functions. Analysis of the mutational events that target the p53 gene has revealed evidence for both exogenous and endogenous mutational mechanisms. For example, the p53 mutational spectrum reveals evidence for a direct causal effect of ultraviolet radiation in skin cancer, of aflatoxin B1 in liver cancer, and of tobacco smoke in lung cancer. This novel field, molecular epidemiology of human cancer risk, has added a new dimension to classical associative epidemiology by providing a direct link between human cancer and carcinogen exposure. For such analysis, we devised a generic software called UMD (Universal Mutation Database). It was developed as a generic software to create locus-specific databases (LSDBs) with the 4(th) Dimension(R) package from ACI. This software includes an optimized structure to assist and secure data entry and to allow the input of various clinical data. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10612830     DOI: 10.1002/(SICI)1098-1004(200001)15:1<105::AID-HUMU19>3.0.CO;2-G

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  61 in total

1.  Determining the identifiability of DNA database entries.

Authors:  B Malin; L Sweeney
Journal:  Proc AMIA Symp       Date:  2000

2.  Chimeric p53 as an alternative therapy for hypoxic tumors.

Authors:  Jun-Ho Lee; Hua Lu
Journal:  Cancer Biol Ther       Date:  2011-01-01       Impact factor: 4.742

3.  CpG methylation of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) and P53 mutation pattern in sporadic colorectal cancer.

Authors:  Rania Abdelmaksoud-Dammak; Amena Saadallah-Kallel; Imen Miladi-Abdennadher; Lobna Ayedi; Abdelmajid Khabir; Tahia Sallemi-Boudawara; Mounir Frikha; Jamel Daoud; Raja Mokdad-Gargouri
Journal:  Tumour Biol       Date:  2015-08-28

4.  Blinded study determination of high sensitivity and specificity microchip electrophoresis-SSCP/HA to detect mutations in the p53 gene.

Authors:  Christa N Hestekin; Jennifer S Lin; Lionel Senderowicz; John P Jakupciak; Catherine O'Connell; Alfred Rademaker; Annelise E Barron
Journal:  Electrophoresis       Date:  2011-10-17       Impact factor: 3.535

5.  Cooperative fluctuations point to the dimerization interface of p53 core domain.

Authors:  Nigar Kantarci; Pemra Doruker; Turkan Haliloglu
Journal:  Biophys J       Date:  2006-07-15       Impact factor: 4.033

6.  Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines.

Authors:  Ying Liu; Walter F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-17       Impact factor: 11.205

Review 7.  Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc.

Authors:  Mu-Shui Dai; Yetao Jin; Jayme R Gallegos; Hua Lu
Journal:  Neoplasia       Date:  2006-08       Impact factor: 5.715

8.  Inhibition of p53 DNA binding function by the MDM2 protein acidic domain.

Authors:  Brittany Cross; Lihong Chen; Qian Cheng; Baozong Li; Zhi-Min Yuan; Jiandong Chen
Journal:  J Biol Chem       Date:  2011-03-17       Impact factor: 5.157

9.  Alterations in K-ras, APC and p53-multiple genetic pathway in colorectal cancer among Indians.

Authors:  Pooja Malhotra; Mumtaz Anwar; Neha Nanda; Rakesh Kochhar; Jai Dev Wig; Kim Vaiphei; Safrun Mahmood
Journal:  Tumour Biol       Date:  2013-03-24

10.  Investigation and prediction of the severity of p53 mutants using parameters from structural calculations.

Authors:  Jonas Carlsson; Thierry Soussi; Bengt Persson
Journal:  FEBS J       Date:  2009-06-25       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.